Compare ADVM & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADVM | PETS |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.6M | 63.7M |
| IPO Year | 2014 | N/A |
| Metric | ADVM | PETS |
|---|---|---|
| Price | $4.36 | $3.01 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 5 | 1 |
| Target Price | ★ $11.60 | $3.20 |
| AVG Volume (30 Days) | 497.5K | ★ 6.9M |
| Earning Date | 11-12-2025 | 02-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $226,972,000.00 |
| Revenue This Year | $1,192.00 | N/A |
| Revenue Next Year | N/A | $2.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.78 | $1.57 |
| 52 Week High | $6.12 | $6.08 |
| Indicator | ADVM | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 58.20 | 72.48 |
| Support Level | $4.15 | $1.69 |
| Resistance Level | $4.23 | $4.05 |
| Average True Range (ATR) | 0.09 | 0.24 |
| MACD | 0.02 | 0.15 |
| Stochastic Oscillator | 95.22 | 55.24 |
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.